WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday. Read More
| Price | 368.90p on 06-05-2026 at 17:50:38 |
|---|---|
| Change | 5.30p 1.46% |
| Buy | 370.80p |
| Sell | 370.50p |
| Last Trade: | Buy 417.00 at 368.90p |
| Day's Volume: | 765,173 |
| Last Close: | 368.90p |
| Open: | 366.70p |
| ISIN: | GB00BP92CJ43 |
| Day's Range | 365.90p - 376.70p |
| 52wk Range: | 320.00p - 610.00p |
| Market Capitalisation: | £1.63b |
| VWAP: | 370.25488p |
| Shares in Issue: | 441.68m |
Tate & Lyle (TATE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 417 | 368.90p | Automatic Execution |
16:35:56 - 06-May-26 |
| Buy* | 3,100 | 368.90p | Automatic Execution |
16:35:55 - 06-May-26 |
| Buy* | 3,800 | 368.90p | Automatic Execution |
16:35:55 - 06-May-26 |
| Sell* | 1,311 | 368.90p | Automatic Execution |
16:35:55 - 06-May-26 |
| Sell* | 1,620 | 368.90p | Automatic Execution |
16:35:55 - 06-May-26 |
| Sell* | 169 | 368.90p | Automatic Execution |
16:35:55 - 06-May-26 |
| Sell* | 41 | 368.90p | Automatic Execution |
16:35:05 - 06-May-26 |
| Sell* | 483,206 | 368.90p | Uncrossing Trade |
16:35:05 - 06-May-26 |
| Sell* | 16 | 370.50p | SI Trade |
16:29:50 - 06-May-26 |
| Buy* | 584 | 370.80p | Automatic Execution |
16:29:36 - 06-May-26 |
Tate & Lyle (TATE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st May 2026 10:00 am | RNS | Total Voting Rights |
| 1st Apr 2026 4:00 pm | RNS | Holding(s) in Company |
| 27th Mar 2026 2:00 pm | RNS | Holding(s) in Company |
| 13th Mar 2026 4:00 pm | RNS | Holding(s) in Company |
| 2nd Mar 2026 2:00 pm | RNS | Holding(s) in Company |
| 26th Feb 2026 7:00 am | RNS | Trading Statement |
| 23rd Feb 2026 10:00 am | RNS | Holding(s) in Company |
| 17th Feb 2026 12:00 pm | RNS | Holding(s) in Company |
| 21st Jan 2026 7:00 am | RNS | Directorate change |
| 15th Jan 2026 9:00 am | RNS | Holding(s) in Company |